Patent 7319097 was granted and assigned to Swedish Orphan Biovitrum on January, 2008 by the United States Patent and Trademark Office.
The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system